ArticleIndian journal of pediatrics2026
Genetic Modulation of One-Carbon Metabolism in Autism Spectrum Disorder: An MTHFR-Based Cross-Sectional Study with Neurotypical Controls.
Article in Indian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesAutism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition in which disruptions in one-carbon metabolism, regulated by methylenetetrahydrofolate reductase (MTHFR), may contribute to phenotypic variability. This study investigated MTHFR C677T and A1298C polymorphisms and their association with serum vitamin B12, folate, and ASD risk in children.
methodsOne hundred children with ASD and 100 age-matched neurotypical controls were enrolled. MTHFR genotyping was performed by allele-specific real-time PCR. Serum vitamin B12 and folate by enzyme-linked immunosorbent assay. Associations were assessed using logistic regression under dominant, additive, and recessive genetic models. Discrimination was evaluated by receiver operating characteristic analysis.
resultsThe C677T TT genotype was overrepresented in ASD cases (57% vs. 43% controls), with significant Hardy-Weinberg deviation (χ² = 21.812, p <0.0001). Mutant A1298C genotypes were observed in 79% of cases. Vitamin B12 declined with increasing C677T T-allele dosage (p <0.001) and folate with A1298C C-allele burden (p = 0.003). Higher vitamin B12 independently associated with reduced ASD odds (OR 0.36, 95% CI 0.17-0.76, p = 0.008). C677T TT homozygosity was significantly associated with increased ASD odds under the recessive model (OR 1.76, 95% CI 1.00-3.08, p = 0.049). A1298C was non-significant across all models, indicating modest discrimination suitable for exploratory purposes only.
conclusionsChildren with ASD showed a high burden of functional MTHFR variants with genotype-linked metabolic variation. TT homozygosity was associated with ASD risk under recessive model, supporting a threshold-dependent genetic effect on one-carbon metabolism. These findings warrant prospective validation in larger independent cohorts.
Indexed as
Identifiers
42766070What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.